Table 2.
Inhibitory zones (mm) of fungal growth in C. albicans and C. auris by bark CEO, leaf CEO and miconazole (10 μg/mL) after 48 h of incubation
| Selected yeasts | Mode of exposure or treatment | Bark CEO | Leaf CEO | Miconazole | |||
|---|---|---|---|---|---|---|---|
| Mean (mm) | SE | Mean (mm) | SE | Mean (mm) | SE | ||
| C. albicans ATCC 10231 | 53.00 | 1.68 | 26.32 | 0.67 | 24.33 | 1.37 | |
| C. albicans ATCC 2091 | Direct contact | 56.68 | 0.85 | 30.17 | 0.76 | 31.33 | 0.97 |
| C. auris NCPF 8971 | 70.40 | 1.53 | 39.67 | 1.00 | 32.82 | 0.39 | |
| C. albicans ATCC 10231 | 55.52 | 0.65 | 15.08 | 0.82 | NA | NA | |
| C. albicans ATCC 2091 | Vapour exposure | 59.72 | 1.07 | 18.90 | 0.33 | NA | NA |
| C. auris NCPF 8971 | 77.37 | 1.72 | 35.40 | 1.08 | NA | NA | |
Results were from three independent experiments performed in triplicate (N = 3)